Microglia only weakly present glioma antigen to cytotoxic T cells
- PMID: 10571416
- DOI: 10.1016/s0736-5748(99)00020-9
Microglia only weakly present glioma antigen to cytotoxic T cells
Abstract
Microglia and brain macrophages represent a substantial fraction of the cells present in astrocytic gliomas. Yet, the functional role of microglia in these tumors has remained enigmatic. We have compared rat microglial cells and thymocytes with regard to their ability to present purified CNS proteins, MBP and S100beta, as well as C6 glioma cells to specific T lymphocytes. In addition, a new cytotoxicity assay based on fluorescence activated cell sorting of tumor cells carrying the green fluorescent protein was established. This assay was used to determine the influence of microglial population density and activational state on C6 glioma cell survival in vitro. Microglia were consistently found to present MBP and S100beta less efficiently than thymocytes and appeared to be unable to present C6 glioma cells to cytotoxic T lymphocytes. In addition, high concentrations of microglial cells attenuated the cytotoxic effects of these T cells on C6 glioma cells whereas thymocytes significantly supported their specific killing. It is suggested that defense functions of microglial cells against C6 glioma are severely compromised and that the observed deficiency in antigen presentation may play an important role for astrocytoma growth in vivo.
Similar articles
-
Microglia in brain tumors.Glia. 2002 Nov;40(2):252-259. doi: 10.1002/glia.10147. Glia. 2002. PMID: 12379912 Review.
-
Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study.J Neurosurg. 2000 Oct;93(4):634-9. doi: 10.3171/jns.2000.93.4.0634. J Neurosurg. 2000. PMID: 11014542
-
Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells.J Neurosurg. 1992 Nov;77(5):757-62. doi: 10.3171/jns.1992.77.5.0757. J Neurosurg. 1992. PMID: 1403119
-
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.Neuro Oncol. 2006 Jul;8(3):261-79. doi: 10.1215/15228517-2006-008. Epub 2006 Jun 14. Neuro Oncol. 2006. PMID: 16775224 Free PMC article.
-
Microglial action in glioma: a boon turns bane.Immunol Lett. 2010 Jun 15;131(1):3-9. doi: 10.1016/j.imlet.2010.03.003. Epub 2010 Mar 23. Immunol Lett. 2010. PMID: 20338195 Review.
Cited by
-
Zonulin as Gatekeeper in Gut-Brain Axis: Dysregulation in Glioblastoma.Biomedicines. 2024 Jul 24;12(8):1649. doi: 10.3390/biomedicines12081649. Biomedicines. 2024. PMID: 39200114 Free PMC article. Review.
-
The molecular profile of microglia under the influence of glioma.Neuro Oncol. 2012 Aug;14(8):958-78. doi: 10.1093/neuonc/nos116. Epub 2012 May 9. Neuro Oncol. 2012. PMID: 22573310 Free PMC article. Review.
-
Rejection of RG-2 gliomas is mediated by microglia and T lymphocytes.J Neurooncol. 2006 Sep;79(3):243-53. doi: 10.1007/s11060-006-9137-x. Epub 2006 Apr 13. J Neurooncol. 2006. PMID: 16612573
-
Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.Neuro Oncol. 2010 Apr;12(4):351-65. doi: 10.1093/neuonc/nop023. Epub 2009 Dec 22. Neuro Oncol. 2010. PMID: 20308313 Free PMC article.
-
CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5.J Neuroimmunol. 2012 May 15;246(1-2):10-7. doi: 10.1016/j.jneuroim.2012.02.009. Epub 2012 Mar 16. J Neuroimmunol. 2012. PMID: 22425022 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous